NANETS Regional NET Education: The Multidisciplinary Management of NET Disease

June 26, 2026

Location: 

Marriott Columbus OSU

3100 Olentangy River Rd, Columbus, OH 43202

7:30am – 4:00pm 

Earn AMA PRA Category 1 Credits,™ and Continuing Nursing Education (ANCC)

Register Now!

Location

Columbus, OH

Course Directors

Jordan Cloyd, MD, Surgical Oncologist, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute; Associate Professor, Division of Surgical Oncology, The Ohio State University Wexner Medical Center

Bhavana Konda, MD, MPH, Physician, Associate Professor, The Ohio State University Comprehensive Cancer Center

 

Overview

Neuroendocrine tumors (NET) are considered to be a rare disease although the frequency of diagnosis has increased over the last ten years. As this is a rare disease, clinicians often do not know how to implement the appropriate care plan and until the last ten years, there was great variability in terms of treatment. The diagnosis, treatment, and management of NETs are time-consuming, complex, and require a multidisciplinary approach. Many healthcare providers who face these challenges are not adequately equipped in their knowledge or experience optimally manage NET disease.

The field of NET research has been evolving with new drug approvals and treatment modalities. In addition, experts in the field of NET disease have continued to develop strategies to improve diagnosis, treatment and management of NET cancers. It is through convening professionals in the areas of oncology, gastroenterology, pulmonology, surgery, radiology and allied fields that the awareness and understanding of NET diseases will expand, resulting in better treatment for NET patients.

Target Audience

This activity is designed for oncologists, gastroenterologists, pulmonologists, surgeons, radiologists, pathologists, primary care physicians, advanced practice nurses, nurses, physician assistants, pharmacists, fellows, students, and other allied health professionals involved with or interested in the treatment of patients with neuroendocrine tumors.

Learning Objectives

Upon completion of this activity, participants should be better able to:

• Review current concepts of neuroendocrine tumor pathology, molecular profile, classification, and grading
• Discuss the various diagnostic processes and use of current and emerging diagnostic tools to determine neuroendocrine tumor type
• Summarize the current safety and efficacy data of the various surgical, medical and loco-regional approaches in the management of neuroendocrine tumors
• Recognize the clinical features associated with carcinoid syndrome
• Apply a multidisciplinary approach to the management of patients with neuroendocrine tumors
• Review clinical trial data and ongoing studies evaluating novel management strategies for the treatment of neuroendocrine tumors

Program

• • Jordan Cloyd, MD, Surgical Oncologist, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute; Associate Professor, Division of Surgical Oncology, The Ohio State University Wexner Medical Center
  • Bhavana Konda, MD, MPH, Physician, Associate Professor, The Ohio State University Comprehensive Cancer Center

• • Background and Pathologic Principles
    Kanika Nair, MD, Associate Member, Gastrointestinal Malignancies Program, Cleveland Clinic
  • Anatomic and Functional Imaging
    TBD
  • Moderator: Jordan Cloyd, MD, Surgical Oncologist, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute; Associate Professor, Division of Surgical Oncology, The Ohio State University Wexner Medical Center

• • Hormonal, Targeted, and Cytotoxic Chemotherapy
    Vineeth Sukrithan, MD, Associate Professor, The Ohio State University College of Medicine
  • PRRT: When is it too early and when too late?
    J. Philip Boudreaux, MD, FACS, Professor of Surgery, Louisiana State University School of Medicine, New Orleans
  • I have heartburn…or is it? The Gastric Carcinoids: Workup, Diagnosis, and Endoscopic Management
    Vikas Prasad, MD, PhD, Professor of Radiology, Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, WashU Medicine
  • Emerging data and what the future holds
    Chandrikha Chandrasekharan, MBBS, Clinical Associate Professor, Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center
  • Moderator: Bhavana Konda, MD, MPH, Physician, Associate Professor, The Ohio State University Comprehensive Cancer Center

• • Cytoreductive Surgery of Liver Metastases
    Patrick P. Starlinger, MD, PhD, Associate Professor of Surgery, Mayo Clinic
  • Transarterial Therapies
    Mina Makary, MD, Associate Professor, Interventional Radiology, The Ohio State University College of Medicine
  • Ablative Therapies: Microwave, SBRT, and Histotripsy
    Eric Miller, MD, PHD, Associate Professor, Radiation Oncology, The Ohio State University College of Medicine
  • Moderator: Jordan Cloyd, MD, Surgical Oncologist, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute; Associate Professor, Division of Surgical Oncology, The Ohio State University Wexner Medical Center

• • Surgical Management of PNETs
    Timothy M Pawlik, MD, PhD, MPH, Professor, Surgical Oncology, The Ohio State University College of Medicine
  • Surgical Management of SB-NETs
    Mary Dillhoff, MD, Associate Professor, Surgery, The Ohio State University College of Medicine
  • Surgical Management of Pulmonary NETs
    Peter Kneuertz, MD, Associate Professor, The Ohio State University College of Medicine
  • Moderator: Jordan Cloyd, MD, Surgical Oncologist, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute; Associate Professor, Division of Surgical Oncology, The Ohio State University Wexner Medical Center

• • Management of Carcinoid Syndrome
    Ye Zhou, APRN-CNP, Nurse Practitioner, The Ohio State University Comprehensive Cancer Center
  • Carcinoid Heart Disease
    Ajay Vallakati, MD, MPH, Associate Professor, Advanced Heart Failure and Transplant Cardiology, Cardiovascular Disease, The Ohio State University College of Medicine
  • Hereditary Syndromes and Genetic Testing for NETs
    Pamela Brock, MS, CGC, Associate Professor, Clinical Associate Director, Genetic Counseling Graduate Program, The Ohio State University College of Medicine
  • Medical Management of Poorly Differentiated NECs: Current landscape and Future directions
    Amr Mohamed, MD, Associate Professor, Director of the Neuroendocrine Tumor Program, UH Seidman Cancer Center, University Hospitals, Case Western Reserve University
  • Moderator: Bhavana Konda, MD, MPH, Physician, Associate Professor, The Ohio State University Comprehensive Cancer Center

• • Case Presenters
    Eren Berber, MD, Professor of Surgery, Vice chair, Department of Endocrine Surgery, Director, Robotic Endocrine Surgery, Cleveland Clinic
    Susan Tsai, MD, MHS, Professor, Director of the Division of Surgical Oncology, The Ohio State University
  • Panelists
    Chandrikha Chandrasekharan, MBBS
    Patrick P. Starlinger
    Vikas Prasad, MD, PhD
  • Moderator: Bhavana Konda, MD, MPH, Physician, Associate Professor, The Ohio State University Comprehensive Cancer Center

• • Jordan Cloyd, MD, Surgical Oncologist, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute; Associate Professor, Division of Surgical Oncology, The Ohio State University Wexner Medical Center

*Program is tentative and subject to change* 

Register Now!

Accreditation

This continuing education activity is provided through collaboration between the North American Endocrine Tumor Society (NANETS) and AffinityCE. This activity provides continuing education credit for physicians, physician assistants, nurse practitioners, and nurses. A statement of participation is available for other attendees.

Physicians, Physician Assistants, and Nurse Practitioners

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the NANETS. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Use of Learner/Participant Data

Participation information will be shared with the applicable certifying board via ACCME PARS.

In order for MOC credit to be reported, evaluations must be completed prior to the close of evaluations.

Nurses

Continuing Nursing Education is provided for this program through the joint providership of AffinityCE and NANETS. AffinityCE is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC). This activity provides a maximum of 5.5 hours of continuing nursing education credit.

Registration fee:

NANETS Member

$65 USD - MD, PharmD, Doctoral Level 
$35 USD - Allied Health
Complimentary - Student/Fellow/Resident

Non-Member

$95 USD - MD, PharmD, Doctoral Level 
$50 USD - Allied Health
Complimentary - Student/Fellow/Resident

Cancellation Policy:

A full refund will be made if registration is canceled, in writing, on or before May 25, 2026. On or after May 26, 2026, no refund will be made.

The North American Neuroendocrine Tumor Society reserves the right to modify the activity content, faculty, and activities, and reserves the right to cancel this activity if necessary. If the program is canceled, liability is limited to the registration fee.

Questions?

Please contact us with any questions.